J. Kenneth Krogulski's Insider Trades & SAST Disclosures
J. Kenneth Krogulski's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 4,000 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Kenneth Krogulski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 4,000 | 282,843 (1%) | 0% | 5.2 | 20,680 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 1,000 | 278,843 (1%) | 0% | 5.2 | 5,170 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 03 Mar 2025 | 47 | 282,937 (1%) | 0% | 5.1 | 240 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.74 per share. | 03 Mar 2025 | 47 | 282,984 (1%) | 0% | 6.7 | 317 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.57 per share. | 03 Mar 2025 | 47 | 283,031 (1%) | 0% | 6.6 | 309 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.51 per share. | 03 Mar 2025 | 47 | 283,078 (1%) | 0% | 6.5 | 306 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 03 Mar 2025 | 47 | 282,890 (1%) | 0% | 5.5 | 260 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 03 Mar 2025 | 45 | 283,718 (1%) | 0% | 4.3 | 193 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.42 per share. | 03 Mar 2025 | 45 | 283,493 (1%) | 0% | 4.4 | 199 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.44 per share. | 03 Mar 2025 | 45 | 283,538 (1%) | 0% | 4.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 03 Mar 2025 | 45 | 283,583 (1%) | 0% | 4.4 | 198 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 03 Mar 2025 | 45 | 283,628 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 03 Mar 2025 | 45 | 283,673 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.84 per share. | 03 Mar 2025 | 37 | 283,115 (1%) | 0% | 5.8 | 216 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 03 Mar 2025 | 37 | 283,152 (1%) | 0% | 4.8 | 179 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.16 per share. | 03 Mar 2025 | 37 | 283,189 (1%) | 0% | 5.2 | 191 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.46 per share. | 03 Mar 2025 | 37 | 283,226 (1%) | 0% | 5.5 | 202 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 03 Mar 2025 | 37 | 283,263 (1%) | 0% | 5.4 | 199 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 03 Mar 2025 | 37 | 283,300 (1%) | 0% | 5.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 03 Mar 2025 | 37 | 283,337 (1%) | 0% | 5.1 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 03 Mar 2025 | 37 | 283,374 (1%) | 0% | 5.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 03 Mar 2025 | 37 | 283,411 (1%) | 0% | 5.1 | 188 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.89 per share. | 03 Mar 2025 | 37 | 283,448 (1%) | 0% | 4.9 | 181 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 02 Dec 2024 | 415 | 272,457 (1%) | 0% | 1.3 | 523 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 02 Dec 2024 | 415 | 272,042 (1%) | 0% | 1.3 | 552 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 02 Dec 2024 | 415 | 273,637 (1%) | 0% | 1.2 | 498 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 02 Dec 2024 | 415 | 272,872 (1%) | 0% | 1.2 | 506 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 02 Dec 2024 | 415 | 274,052 (1%) | 0% | 1.3 | 519 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 02 Dec 2024 | 350 | 273,222 (1%) | 0% | 1.2 | 420 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 02 Dec 2024 | 312 | 275,776 (1%) | 0% | 2.2 | 683 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 02 Dec 2024 | 312 | 275,152 (1%) | 0% | 2.2 | 690 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 02 Dec 2024 | 312 | 275,464 (1%) | 0% | 2.1 | 661 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 02 Dec 2024 | 301 | 276,343 (1%) | 0% | 2.3 | 707 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 02 Dec 2024 | 266 | 276,042 (1%) | 0% | 2.3 | 620 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 02 Dec 2024 | 197 | 274,446 (1%) | 0% | 2.3 | 451 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 02 Dec 2024 | 197 | 274,840 (1%) | 0% | 2.3 | 459 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 02 Dec 2024 | 197 | 274,249 (1%) | 0% | 2.5 | 489 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 02 Dec 2024 | 197 | 274,643 (1%) | 0% | 2.2 | 431 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 01 Nov 2024 | 474 | 271,627 (1%) | 0% | 1.3 | 626 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 01 Nov 2024 | 474 | 270,205 (1%) | 0% | 1.1 | 517 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 01 Nov 2024 | 474 | 271,153 (1%) | 0% | 1.1 | 545 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 01 Nov 2024 | 474 | 270,679 (1%) | 0% | 1.1 | 526 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 01 Nov 2024 | 474 | 269,731 (1%) | 0% | 1.1 | 507 | Common Stock |
| Cumberland Pharmaceuticals... | J. Krogulski Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 01 Nov 2024 | 427 | 268,830 (1%) | 0% | 1.1 | 483 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 01 Nov 2024 | 427 | 269,257 (1%) | 0% | 1.1 | 465 | Common Stock |
| Cumberland Pharmaceuticals... | J. Krogulski Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 01 Nov 2024 | 380 | 268,023 (1%) | 0% | 1.2 | 448 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Nov 2024 | 380 | 266,123 (1%) | 0% | 1.2 | 456 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 01 Nov 2024 | 380 | 267,643 (1%) | 0% | 1.2 | 445 | Common Stock |
| Cumberland Pharmaceuticals... | J. Krogulski Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 01 Nov 2024 | 380 | 263,978 (1%) | 0% | 1.2 | 437 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 01 Nov 2024 | 380 | 265,363 (1%) | 0% | 1.2 | 445 | Common Stock |
| Cumberland Pharmaceuticals... | J. Krogulski Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Nov 2024 | 380 | 266,503 (1%) | 0% | 1.2 | 456 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Nov 2024 | 380 | 266,883 (1%) | 0% | 1.2 | 456 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 01 Nov 2024 | 380 | 267,263 (1%) | 0% | 1.2 | 452 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 01 Nov 2024 | 380 | 265,743 (1%) | 0% | 1.2 | 448 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Nov 2024 | 380 | 264,983 (1%) | 0% | 1.2 | 456 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Nov 2024 | 380 | 264,603 (1%) | 0% | 1.2 | 456 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 01 Nov 2024 | 380 | 268,403 (1%) | 0% | 1.2 | 437 | Common Stock |
| Cumberland Pharmaceuticals... | J. Krogulski Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 01 Nov 2024 | 245 | 264,223 (1%) | 0% | 1.2 | 287 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 01 Oct 2024 | 309 | 263,598 (1%) | 0% | 1.2 | 371 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 01 Oct 2024 | 309 | 256,800 (1%) | 0% | 1.3 | 392 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 01 Oct 2024 | 309 | 257,109 (1%) | 0% | 1.3 | 399 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 01 Oct 2024 | 309 | 257,418 (1%) | 0% | 1.3 | 396 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 01 Oct 2024 | 309 | 257,727 (1%) | 0% | 1.3 | 396 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 01 Oct 2024 | 309 | 258,036 (1%) | 0% | 1.3 | 399 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 01 Oct 2024 | 309 | 258,345 (1%) | 0% | 1.3 | 402 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 01 Oct 2024 | 309 | 258,654 (1%) | 0% | 1.3 | 405 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 01 Oct 2024 | 309 | 258,963 (1%) | 0% | 1.3 | 408 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 01 Oct 2024 | 309 | 259,272 (1%) | 0% | 1.4 | 430 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 01 Oct 2024 | 309 | 259,581 (1%) | 0% | 1.4 | 423 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 01 Oct 2024 | 309 | 259,890 (1%) | 0% | 1.3 | 402 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 01 Oct 2024 | 309 | 260,199 (1%) | 0% | 1.2 | 386 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 01 Oct 2024 | 309 | 260,508 (1%) | 0% | 1.3 | 402 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 01 Oct 2024 | 309 | 260,817 (1%) | 0% | 1.3 | 396 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 01 Oct 2024 | 309 | 261,126 (1%) | 0% | 1.2 | 386 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 01 Oct 2024 | 309 | 261,435 (1%) | 0% | 1.2 | 386 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 01 Oct 2024 | 309 | 261,744 (1%) | 0% | 1.3 | 389 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 01 Oct 2024 | 309 | 262,053 (1%) | 0% | 1.2 | 383 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 01 Oct 2024 | 309 | 262,362 (1%) | 0% | 1.2 | 380 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 01 Oct 2024 | 309 | 262,671 (1%) | 0% | 1.2 | 386 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 01 Oct 2024 | 309 | 262,980 (1%) | 0% | 1.2 | 383 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 01 Oct 2024 | 309 | 263,289 (1%) | 0% | 1.3 | 408 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 309 | 256,491 (1%) | 0% | 1.4 | 420 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 252,277 (1%) | 0% | 1.4 | 345 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 255,961 (1%) | 0% | 1.2 | 310 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 255,441 (1%) | 0% | 1.3 | 313 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 255,191 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 254,941 (1%) | 0% | 1.3 | 323 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 254,691 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 254,441 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 254,191 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 253,941 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 253,691 (1%) | 0% | 1.4 | 338 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 250 | 253,047 (1%) | 0% | 1.3 | 333 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 241 | 253,441 (1%) | 0% | 1.3 | 325 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 238 | 252,515 (1%) | 0% | 1.3 | 321 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 230 | 252,745 (1%) | 0% | 1.3 | 294 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 221 | 256,182 (1%) | 0% | 1.2 | 274 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 197 | 255,711 (1%) | 0% | 1.3 | 254 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 153 | 253,200 (1%) | 0% | 1.3 | 199 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 73 | 255,514 (1%) | 0% | 1.2 | 89 | Common Stock | |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | 03 Sep 2024 | 52 | 252,797 (1%) | 0% | 1.3 | 68 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges